134 related articles for article (PubMed ID: 2028452)
1. Changes in platelet function and reactivity induced by quinine in relation to quinine (drug) induced immune thrombocytopenia.
Connellan JM; Deacon S; Thurlow PJ
Thromb Res; 1991 Mar; 61(5-6):501-14. PubMed ID: 2028452
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies.
Chong BH; Du XP; Berndt MC; Horn S; Chesterman CN
Blood; 1991 May; 77(10):2190-9. PubMed ID: 1709374
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: involvement of glycoproteins Ib, IIb, IIIa, and IX.
Pfueller SL; Bilston RA; Logan D; Gibson JM; Firkin BG
Blood; 1988 Oct; 72(4):1155-62. PubMed ID: 2971407
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies.
Asvadi P; Ahmadi Z; Chong BH
Blood; 2003 Sep; 102(5):1670-7. PubMed ID: 12738668
[TBL] [Abstract][Full Text] [Related]
5. Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia.
Christie DJ; Leja DN; Carlson DL; Swinehart CD
J Lab Clin Med; 1993 Mar; 121(3):437-43. PubMed ID: 7680369
[TBL] [Abstract][Full Text] [Related]
6. Quinine- and quinidine platelet antibodies can react with GPIIb/IIIa.
Christie DJ; Mullen PC; Aster RH
Br J Haematol; 1987 Oct; 67(2):213-9. PubMed ID: 3676108
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
[TBL] [Abstract][Full Text] [Related]
9. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil proteinase cathepsin G is proteolytically active on the human platelet glycoprotein Ib-IX receptor: characterization of the cleavage sites within the glycoprotein Ib alpha subunit.
Pidard D; Renesto P; Berndt MC; Rabhi S; Clemetson KJ; Chignard M
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):489-98. PubMed ID: 7980408
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced immune thrombocytopenia: Mapping of the drug binding site to the membrane-proximal region of platelet GPIX.
Ahmadi Z; Perdomo J; Wong R; Chong BH
Platelets; 2019; 30(2):251-255. PubMed ID: 29286872
[TBL] [Abstract][Full Text] [Related]
12. Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production in vitro.
Perdomo J; Yan F; Ahmadi Z; Jiang XM; Stocker R; Chong BH
Blood; 2011 Jun; 117(22):5975-86. PubMed ID: 21487107
[TBL] [Abstract][Full Text] [Related]
13. Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia.
Christie DJ; Aster RH
J Clin Invest; 1982 Nov; 70(5):989-98. PubMed ID: 6215430
[TBL] [Abstract][Full Text] [Related]
14. Heterogenous inhibition of platelet aggregation by monoclonal antibodies binding to multiple sites on GPIIIa.
Liu LX; Nardi MA; Nierodzik ML; Karpatkin S
Br J Haematol; 1995 Dec; 91(4):976-82. PubMed ID: 8547151
[TBL] [Abstract][Full Text] [Related]
15. Differing susceptibilities of platelets from normal individuals and patients with von Willebrand's disease to attack by quinine- and quinidine-dependent antiplatelet antibodies.
Pfueller SL; Bilston RA; Logan D; David R; Sloan IG; Firkin BG
Thromb Haemost; 1989 Feb; 61(1):111-6. PubMed ID: 2787540
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
Peter K; Straub A; Kohler B; Volkmann M; Schwarz M; Kübler W; Bode C
Am J Cardiol; 1999 Sep; 84(5):519-24. PubMed ID: 10482148
[TBL] [Abstract][Full Text] [Related]
17. Expression of the drug-dependent antigen for quinine-dependent antiplatelet antibodies on GP IIIa but not that on GPIb, IIb or IX on human endothelial cells.
Pfueller SL; Bilston RA; Jane S; Gibson J
Thromb Haemost; 1990 Apr; 63(2):279-81. PubMed ID: 2363128
[TBL] [Abstract][Full Text] [Related]
18. Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies.
Bougie DW; Wilker PR; Aster RH
Blood; 2006 Aug; 108(3):922-7. PubMed ID: 16861345
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms.
Curtis BR
Immunohematology; 2014; 30(2):55-65. PubMed ID: 25247620
[TBL] [Abstract][Full Text] [Related]
20. Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoene.
Apitz-Castro R; Jain MK; Bartoli F; Ledezma E; Ruiz MC; Salas R
Biochim Biophys Acta; 1991 Sep; 1094(3):269-80. PubMed ID: 1911878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
